Flagship explainer
How CUMBERLAND PHARMACEUTICALS INC makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $44.5M | 100% |
| |
| Cost of revenue | $6.7M | 15% |
|
| $37.9M | 85% |
| |
| −$2.8M | −6% |
| |
| Income before tax | −$2.8M | −6% |
|
| Income tax | $40256 | 0% |
|
| −$2.8M | −6% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001087294-26-000020